The Power Of Two, The Ease Of One: Two Experts, One Streamlined Solution

The development and clinical use of antibody-drug conjugates (ADCs) are rapidly gaining momentum, driving increased demand for contract development and manufacturing services. In response to this, Simtra BioPharma Solutions and MilliporeSigma have formed a strategic alliance to accelerate the delivery of these complex therapies and other bioconjugates to patients.

As industry-leading CDMOs, both with over 10 years of experience in ADC manufacturing, this partnership offers a quality-focused, turnkey solution. The integrated process covers the entire manufacturing lifecycle, from initial project contracting to ADC Drug Fill/Finish, with close collaboration and quality testing throughout.

This approach provides multiple benefits, including a simplified supply chain, fewer CDMOs to screen, synchronized fill slot scheduling, and harmonized processes. This alliance enables pharma and biopharma companies to reduce complexity, shorten timelines, and focus on continued drug discovery. Explore the benefits and the streamlined manufacturing process.